Tilray and Curaleaf Stocks Surge as DEA Considers Reclassifying Marijuana

The Drug Enforcement Agency is looking at whether to reclassify marijuana into a less hazardous category, and cannabis stocks are soaring.

The U.S. Department of Health and Human Services wrote to the Drug Enforcement Agency asking for cannabis to be classified as a Schedule III drug, as opposed to its current Schedule I, according to a letter dated Tuesday viewed by Bloomberg News. Schedule I includes substances such as Ecstasy and heroin. Substances in Schedule III include Tylenol with Codeine.

A DEA spokesperson confirmed that the agency has received the letter. “HHS conducted a scientific and medical evaluation for consideration by DEA,” pursuant to a request by President Joe Biden, the spokesperson said Wednesday. “DEA has the final authority to schedule or reschedule a drug under the Controlled Substances Act. DEA will now initiate its review.

المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

U.S. crude stocks plunge 11M barrels last week; fuel stocks upU.S. crude stocks plunge 11M barrels last week; fuel stocks up - API
مصدر: Investingcom - 🏆 450. / 53 اقرأ أكثر »

Japanese stocks rise for third day as Hong Kong stocks hold steadyStocks in the Asia-Pacific region increased Wednesday, Aug. 30, the Japanese market showing a third day of increases. Hong Kong stocks were flat, with the...
مصدر: MarketWatch - 🏆 3. / 97 اقرأ أكثر »